YieldMax AI & Tech Portfolio Option Income ETF (GPTY) Stock Price Today
Key Stats
- -Market Cap
- -Volume
- Income / Options OverlaySector
- $50.5252W High
- $34.7352W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track YieldMax AI & Tech Portfolio Option Income ETF (GPTY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, YieldMax AI & Tech Portfolio Option Income ETF has traded between a low of $34.73 and a high of $50.52, highlighting its annual price range. Buy and sell YieldMax AI & Tech Portfolio Option Income ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About YieldMax AI & Tech Portfolio Option Income ETF
GPTY is an actively managed ETF that seeks to provide current income and capital appreciation by holding a concentrated portfolio of 15 to 30 leading AI and technology companies. It utilizes a variety of options strategies, including selling call options on its underlying holdings, to generate weekly distributions while maintaining direct equity exposure to the growth of the AI sector.
Most Recent News
Intel shares jump on High-NA EUV tech progress and $120 price target upgrade
Intel's stock surged after Northland Securities upgraded it from "Market Perform" to "Outperform" with a $120 price target, following Intel Foundry's progress in High Numerical Aperture Extreme Ultraviolet (High-NA EUV) lithography. Intel has process...
Amazon sued for allegedly discriminating against pregnant workers nationwide.
Amazon faces a proposed nationwide class action lawsuit accusing it of discriminating against pregnant employees by denying basic accommodations and firing those who take too much time off. The complaint, filed by four former warehouse workers, alleg...
Class action lawsuit filed against Beta Bionics over faulty insulin pump issues.
A class action lawsuit has been filed against Beta Bionics for allegedly making false statements about its iLet Bionic Pancreas insulin pump. The FDA reportedly found serious safety issues with the device, including dangerous insulin dosing causing h...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.